J. Vanichanan

Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.

E. Shpall, R. Chemaly, E. Ariza-Heredia, 2016, Antiviral research.

A pseudo‐outbreak of disseminated cryptococcal disease after orthotopic heart transplantation

P. Loyalka, I. Gregoric, A. Wanger, 2016, Mycoses.